Mariner’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Mariner’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Sell	39,997 -3	-0%	–	﹤0.01%	3539
2025 Q4	$2.51K	Buy	+40,000	New	+$1.96K	﹤0.01%	3521

Other funds holding SXTPW

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mariner's SXTPW Position: Q1 2026 in Review

Mariner reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 0.01% in Q1 2026, cutting 3 shares and leaving 39,997 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3539.

Mariner first reported a position in SXTPW in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.51K in Q4 2025. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

Mariner held 39,997 shares of 60 Degrees Pharmaceuticals Warrant worth $2K as of Q1 2026.
Mariner sold 3 60 Degrees Pharmaceuticals Warrant shares in Q1 2026.
60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3539 holding.
Mariner first reported a position in 60 Degrees Pharmaceuticals Warrant in Q4 2025 and has held it in 2 quarters since.
Mariner's 60 Degrees Pharmaceuticals Warrant position peaked at $2.51K in Q4 2025.
8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.